Form 4: Aclaris Therapeutics Executive Neal Walker Reports Stock Transactions
SEC Form 4 Filing
Neal Walker, Interim President and CEO of Aclaris Therapeutics, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On July 1, 2024, Neal Walker, Interim President and CEO of Aclaris Therapeutics, engaged in transactions involving Aclaris Therapeutics common stock.
- Walker acquired 9,467 shares of common stock through the vesting of restricted stock units.
- Simultaneously, Walker disposed of 2,722 shares to cover tax withholding obligations at a price of $1.15 per share.
- Following these transactions, Walker directly owns 1,305,860 shares of Aclaris Therapeutics common stock and 94,667 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It is a standard practice for executives to receive and vest restricted stock units as part of their compensation.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the executive's holdings, but the overall impact is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of stock transactions (acquisition and disposal) and vesting of restricted stock units. |
| 07/03/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.